Abstract:Based on the potent antidepressant and anticonvulsant activities of the triazole-containing quinolinones reported in our previous work, a series of ring-opened derivatives of them were designed, synthesized in this work. Their antidepressant and anticonvulsant activities were screened using the forced swimming test (FST) and the maximal electroshock seizure test (MES), respectively. The results showed that compounds 4a, 5a, 6c-6e, 6g-6i, and 7 led to significant reductions in the accumulated immobility time in the FST at a dose of 50 mg/kg. Especially compound 7 exhibited higher levels of efficacy than the reference standard fluoxetine in the FST and the tail suspension test. The results of an open field test excluded the possibility of central nervous stimulation of 7, which further confirmed its antidepressant effect. Meanwhile, compounds 6a-6i and 7 showed different degrees of anticonvulsant activity in mice at the doses range from 300 to 30 mg/kg in the MES. Among them, compounds 6e and 7 displayed the ED50 of 38.5 and 32.7 mg/kg in the MES, and TD50 of 254.6 and 245.5 mg/kg, respectively. No one showed neurotoxicity at the dose of 100 mg/kg. The preliminary investigation forward to their mechanism indicated that regulation of GABAergic system might contribute to their anticonvulsive and anti-depressive action.

Synthesis and Evaluation on Anticonvulsant and Antidepressant Activities of 5‐Alkoxy‐tetrazolo[1,5‐a]quinazolines

Synthesis and Studies on Anticonvulsant and Antidepressant Activities of 5-Alkoxy-tetrazolo[1,5-a]quinolines

Design, synthesis and evaluation of the antidepressant and anticonvulsant activities of triazole-containing quinolinones.

Synthesis and Anticonvulsant Activity of 7-Alkoxyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolines

Synthesis and Anticonvulsant Activity of 5‐Phenyl‐[1,2,4]‐triazolo[4,3‐a]quinolines

Synthesis and Anticonvulsant Activity Evaluation of 4-Phenyl-[1,2,4]triazolo[4,3-a]quinazolin-5(4h)-one and Its Derivatives

Synthesis and anticonvulsant activity evaluation of 5-phenyl-[1,2,4]triazolo[4,3-c]quinazolin-3-amines.

Synthesis and Neuroprotective Biological Evaluation of Quinazolinone Derivatives Via Scaffold Hopping.

Synthesis and anticonvulsant activity evaluation of 8-alkoxy-5-(4 H -1,2,4-triazol-4-yl)quinoline derivatives

Design and synthesis of 6-alkyoxyl[1,2,4]triazolo[1,5- a ]quinazoline derivatives with anticonvulsant activity

Synthesis of 6-Alkyloxyl-3,4-dihydro-2(1h)-quinoliones and Their Anticonvulsant Activities

Synthesis and Antidepressant Activities of 4-(Substituted-phenyl)tetrazolo[1,5-a]quinazolin-5(4h)-ones and Their Derivatives

Synthesis and anticonvulsant activity of 1-substituted-7-benzyloxy-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline.

Synthesis and Anticonvulsant Activity of 5-Substituted-[1,2,4]triazolo[4,3-a]quinazolines

Synthesis and Anticonvulsant Activities of 4-Alkoxyl-[1,2,4]Triazolo[4,3-a]Quinoxaline Derivatives

Synthesis and Evaluation of the Antidepressant Activity of Quinoxaline-2,3(1H,4H)-dione Derivatives

Synthesis and Evaluation of Anticonvulsant and Antidepressant Activities of 5-Alkoxytetrazolo[1,5-c]thieno[2,3-e]pyrimidine Derivatives

Design, Synthesis of 8-Alkoxy-5,6-dihydro-[1,2,4]triazino[4,3-a]quinolin-1-ones with Anticonvulsant Activity

Synthesis of 2-Substituted-7-heptyloxy-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolin-1(2 H)-Ones with Anticonvulsant Activity

The Synthesis and Anticonvulsant Activity of 1-Substituted-7-methoxy-1,2,4-triazolo [4, 3-A] Quinoline

Synthesis of ring-opened derivatives of triazole-containing quinolinones and their antidepressant and anticonvulsant activities